Korea scientist found carcinogenic mechanism by FH defect

Published: 2005-09-12 07:00:00

Updated: 2005-09-12 07:00:00

Prof. Chung Yeong-jin of Busan National Univ. College of Pharmacy reported his study on the August edition of a world medical journal "Cancer Cell" about a molecular level of the carcinogenic mechanism by an FH (fumarate hydratase) genetic mutation. FH is an enzyme involved in the TCA cycle at th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK